scholarly journals JIP2 haploinsufficiency contributes to neurodevelopmental abnormalities in human pluripotent stem cell-derived neural progenitors and cortical neurons

2017 ◽  
Author(s):  
Reinhard Roessler ◽  
Johanna Goldmann ◽  
Chikdu Shivalila ◽  
Rudolf Jaenisch

AbstractPhelan-McDermid syndrome (also known as 22q13 deletion syndrome) is a syndromic form of autism spectrum disorder and currently thought to be caused by heterozygous loss of SHANK3. However, patients most frequently present with large chromosomal deletions affecting several additional genes. We used human pluripotent stem cell technology and genome editing to further dissect molecular and cellular mechanisms. We found that loss of JIP2 (MAPK8IP2) may contribute to a distinct neurodevelopmental phenotype in neural progenitors (NPCs) affecting neuronal maturation. This is most likely due to simultaneous misregulation of JNK proteins, leading to impaired generation of mature neurons. Furthermore, semaphorin signaling is compromised in patient NPCs and neurons. Pharmacological stimulation of neuropilin receptor 1 (NRP1) rescued impaired semaphorin pathway activity and JNK expression in patient neurons. Our results suggest a novel disease-specific mechanism involving the JIP/JNK complex and identify NRP1 as potential therapeutic target.

2018 ◽  
Vol 1 (4) ◽  
pp. e201800094 ◽  
Author(s):  
Reinhard Roessler ◽  
Johanna Goldmann ◽  
Chikdu Shivalila ◽  
Rudolf Jaenisch

Phelan–McDermid syndrome (also known as 22q13.3 deletion syndrome) is a syndromic form of autism spectrum disorder and currently thought to be caused by heterozygous loss of SHANK3. However, patients most frequently present with large chromosomal deletions affecting several additional genes. We used human pluripotent stem cell technology and genome editing to further dissect molecular and cellular mechanisms. We found that loss of JIP2 (MAPK8IP2) may contribute to a distinct neurodevelopmental phenotype in neural progenitor cells (NPCs) affecting neuronal maturation. This is most likely due to a simultaneous down-regulation of c-Jun N-terminal kinase (JNK) proteins, leading to impaired generation of mature neurons. Furthermore, semaphorin signaling appears to be impaired in patient NPCs and neurons. Pharmacological activation of neuropilin receptor 1 (NRP1) rescued impaired semaphorin pathway activity and JNK expression in patient neurons. Our results suggest a novel disease-specific mechanism involving the JIP/JNK complex and identify NRP1 as a potential new therapeutic target.


Gene Therapy ◽  
2011 ◽  
Vol 19 (5) ◽  
pp. 469-475 ◽  
Author(s):  
S Iyer ◽  
E Xiao ◽  
K Alsayegh ◽  
N Eroshenko ◽  
M J Riggs ◽  
...  

EBioMedicine ◽  
2016 ◽  
Vol 9 ◽  
pp. 293-305 ◽  
Author(s):  
Hélène Darville ◽  
Aurélie Poulet ◽  
Frédérique Rodet-Amsellem ◽  
Laure Chatrousse ◽  
Julie Pernelle ◽  
...  

Open Biology ◽  
2018 ◽  
Vol 8 (9) ◽  
pp. 180138 ◽  
Author(s):  
Era Taoufik ◽  
Georgia Kouroupi ◽  
Ourania Zygogianni ◽  
Rebecca Matsas

Synaptic dysfunction in CNS disorders is the outcome of perturbations in physiological synapse structure and function, and can be either the cause or the consequence in specific pathologies. Accumulating data in the field of neuropsychiatric disorders, including autism spectrum disorders, schizophrenia and bipolar disorder, point to a neurodevelopmental origin of these pathologies. Due to a relatively early onset of behavioural and cognitive symptoms, it is generally acknowledged that mental illness initiates at the synapse level. On the other hand, synaptic dysfunction has been considered as an endpoint incident in neurodegenerative diseases, such as Alzheimer's, Parkinson's and Huntington's, mainly due to the considerably later onset of clinical symptoms and progressive appearance of cognitive deficits. This dichotomy has recently been challenged, particularly since the discovery of cell reprogramming technologies and the generation of induced pluripotent stem cells from patient somatic cells. The creation of ‘disease-in-a-dish’ models for multiple CNS pathologies has revealed unexpected commonalities in the molecular and cellular mechanisms operating in both developmental and degenerative conditions, most of which meet at the synapse level. In this review we discuss synaptic dysfunction in prototype neurodevelopmental and neurodegenerative diseases, emphasizing overlapping features of synaptopathy that have been suggested by studies using induced pluripotent stem-cell-based systems. These valuable disease models have highlighted a potential neurodevelopmental component in classical neurodegenerative diseases that is worth pursuing and investigating further. Moving from demonstration of correlation to understanding mechanistic causality forms the basis for developing novel therapeutics.


Cell Reports ◽  
2018 ◽  
Vol 23 (9) ◽  
pp. 2732-2743 ◽  
Author(s):  
Ira Espuny-Camacho ◽  
Kimmo A. Michelsen ◽  
Daniele Linaro ◽  
Angéline Bilheu ◽  
Sandra Acosta-Verdugo ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document